CD274 and neoplasm: NP-TOS15 downregulated PD-L1 expression, and the combination therapy enhanced cytotoxic lymphocyte tumor infiltration, inhibiting tumor growth and preventing lung metastasis in 4T1 breast tumor-bearing mice [247].